II.3 Tamoxifen and uterine fibroids

Tamoxifen, an anti-estrogen widely used for breast cancer treatment, has variable agonistic effects on the uterus (mostly concerning endometrium but also myometrium). 14 cases of growing uterine fibroleiomyomas during tamoxifen treatment which required hysterectomy are described. No myometrial malig...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of cancer (1990) Vol. 34; pp. S19 - S21
Main Authors Le Bouëdec, G., De Latour, M., Dauplat, J.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 1998
Online AccessGet full text

Cover

More Information
Summary:Tamoxifen, an anti-estrogen widely used for breast cancer treatment, has variable agonistic effects on the uterus (mostly concerning endometrium but also myometrium). 14 cases of growing uterine fibroleiomyomas during tamoxifen treatment which required hysterectomy are described. No myometrial malignancy was observed.
ISSN:0959-8049
1879-0852
DOI:10.1016/S0959-8049(98)00092-6